I collaborated with Eyeforpharma to delve into the dimensions of moving toward patient centrality in clinical trials.
Read below the concept of the new paradigm and the full report:
“In this new paradigm, positive patient experiences and patient outcomes with high recruitment, adherence and retention result from alignment of the HEART, HEAD and HANDS within the research sponsor’s organization and among all key stakeholders. Alignment around a truly patient-centered vision, values and strategy and walking the talk are the foundation of trust.”
More from Joyce
The Signitt Network
Tags: Joyce Avedisian, Catalyst for Culture Change and Superior Performance, Signitt